highly significantp < 0.01
However, upon the antibiotic treatment at 48 weeks, there were highly significant differences between the groups (PERMANOVA; Bray–Curtis dissimilarity; p < 0.01).
However, upon the antibiotic treatment at 48 weeks, there were highly significant differences between the groups (PERMANOVA; Bray–Curtis dissimilarity; p < 0.01).
At baseline, β-diversity analysis revealed a borderline significant difference in the bacterial composition between the placebo and AZM groups (PERMANOVA; Bray–Curtis dissimilarity; p = 0.06).